We found no evidence for expression in tissue of ten proteins altered during BRAFi and MEKi treatment, among them CPB1, PNLIP, PRSS1, SERPINA6, FGG, and F9; all of them increased during treatment and likely not derived from cancer tissue. Here, CPB1 is linked to cancer.